Literature DB >> 17556161

Risk stratification after acute myocardial infarction: is it time to reassess? Implications from the INSPIRE trial.

John J Mahmarian, Craig M Pratt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17556161     DOI： 10.1016/j.nuclcard.2007.04.007

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  35 in total

1.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group.

Authors:  L J Shaw; R Hachamovitch; D S Berman; T H Marwick; M S Lauer; G V Heller; A E Iskandrian; K L Kesler; M I Travin; H C Lewin; R C Hendel; S Borges-Neto; D D Miller
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

2.  5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.

Authors:  K A A Fox; P Poole-Wilson; T C Clayton; R A Henderson; T R D Shaw; D J Wheatley; R Knight; S J Pocock
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.

Authors:  R Spacek; P Widimský; Z Straka; E Jiresová; J Dvorák; R Polásek; I Karel; R Jirmár; L Lisa; T Budesínský; F Málek; P Stanka
Journal:  Eur Heart J       Date:  2002-02       Impact factor: 29.983

5.  Prognostic value of adenosine Tl-201 myocardial perfusion imaging after acute myocardial infarction: results of a prospective clinical trial.

Authors:  Habib A Dakik; Juliet A Wendt; Kay Kimball; Craig M Pratt; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

6.  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.

Authors: 
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

Review 7.  The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction.

Authors:  Marc S Sabatine; Elliott M Antman
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

8.  Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study.

Authors:  H A Dakik; N S Kleiman; J A Farmer; Z X He; J A Wendt; C M Pratt; M S Verani; J J Mahmarian
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

9.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

Authors: 
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

10.  Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction.

Authors:  M I Travin; A Dessouki; T Cameron; G V Heller
Journal:  Am J Cardiol       Date:  1995-04-01       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.